ArticleInvestigational new drugs2024

Depth of response and treatment outcomes of immune checkpoint inhibitor-based therapy in patients with advanced non-small cell lung cancer and high PD-L1 expression: An exploratory analysis of retrospective multicenter cohort.

Yusuke Tachibana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.